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Tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxyge-
nase (IDO) constitute an important, yet relatively poorly under-
stood, family of heme-containing enzymes. Here, we report ex-
tensive structural and biochemical studies of the Xanthomonas
campestris TDO and a related protein SO4414 from Shewanella
oneidensis, including the structure at 1.6-Å resolution of the
catalytically active, ferrous form of TDO in a binary complex with
the substrate L-Trp. The carboxylate and ammonium moieties of
tryptophan are recognized by electrostatic and hydrogen-bonding
interactions with the enzyme and a propionate group of the heme,
thus defining the L-stereospecificity. A second, possibly allosteric,
L-Trp-binding site is present at the tetramer interface. The sixth
coordination site of the heme-iron is vacant, providing a dioxygen-
binding site that would also involve interactions with the ammo-
nium moiety of L-Trp and the amide nitrogen of a glycine residue.
The indole ring is positioned correctly for oxygenation at the C2
and C3 atoms. The active site is fully formed only in the binary
complex, and biochemical experiments confirm this induced-fit
behavior of the enzyme. The active site is completely devoid of
water during catalysis, which is supported by our electrochemical
studies showing significant stabilization of the enzyme upon
substrate binding.
cancer  heme enzymes  immunomodulation  indoleamine
2,3-dioxygenase
Tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO) catalyze the oxidative cleavage of the
L-tryptophan (L-Trp) pyrrole ring, the first and rate-limiting step
in L-Trp catabolism through the kynurenine pathway (1–3). In
addition, IDO has been implicated in a diverse range of physi-
ological and pathological conditions, including suppression of T
cell proliferation, maternal tolerance to allogenic fetus, and
immune escape of cancers (4–8), and is an attractive target for
drug discovery against cancer and autoimmune and other dis-
eases (2, 9–12).
Despite catalyzing identical biochemical reactions (Fig. 1a),
the sequence similarity between TDO and IDO is extremely low.
An alignment of their sequences is only possible based on their
structures, which suggests a sequence identity of 10% between
them (Fig. 1b). In comparison, Xanthomonas campestris TDO
shares 34% sequence identity with human TDO (Fig. 1b),
demonstrating the remarkable evolutionary conservation of this
enzyme. TDO is a homotetrameric enzyme and is highly specific
for L-Trp and related derivatives such as 6-fluoro-Trp as the
substrate. In comparison, IDO is monomeric, and shows activity
toward a larger collection of substrates, including L-Trp, D-
tryptophan (D-Trp), serotonin, and tryptamine (3), although the
Km for D-Trp is 100-fold higher than that for L-Trp (13). The
structure of human IDO in the catalytically inactive, ferric
[Fe(III)]-heme state in complex with the 4-phenylimidazole
inhibitor has recently been reported (14). Although this struc-
ture gave information about important active site residues, the
inhibitor is coordinated to the heme iron and does not provide
any information regarding Trp or oxygen binding.
To provide direct insight into substrate recognition and ca-
talysis by these enzymes, we report here the crystal structures at
up to 1.6-Å resolution of the active, reduced (Fe(II)) TDO from
X. campestris in a binary complex with the substrate L-Trp or
6-fluoro-Trp. Our structures reveal for the first time the struc-
tural basis for the stereospecificity of this important enzyme. Our
structural information is confirmed by biochemical studies and
offers significant molecular insight into tryptophan dioxygen-
ation by TDO and IDO.
Results
Structure Determination. Crystals of the reduced (Fe(II)) TDO
from X. campestris in a binary complex with the substrate L-Trp
or 6-fluoro-Trp were obtained after extensive efforts and by
using anaerobic conditions, because the oxidized (Fe(III)) en-
zyme has much lower affinity for L-Trp (see below). The
structures at up to 1.6-Å resolution of these binary complexes
[Table 1; and see supporting information (SI) Table 3] as well as
that of the free enzyme were determined by molecular replace-
ment based on the structure of the apo enzyme, in the absence
of heme, which we had determined by the selenomethionyl
single-wavelength anomalous diffraction method (PDB entry
1YW0) (15).
The structure of the SO4414 protein from Shewanella onei-
densis (16) was determined at 2.4-Å resolution by molecular
replacement based on our structure of the apo enzyme (PDB
entry 1ZEE).
Structure of TDO. The structure of X. campestris TDO monomer
contains 12 helices (named A through L) and no -strands
(Figs. 1b and 2a). TDO is an intimately associated tetramer (Fig.
2b), and 4,500 Å2 of the surface area of each monomer is
buried in the tetramer. Helices B and C are located in the
extensive, mostly hydrophobic interface between two of the
monomers. The N-terminal segments (residues 21–40, including
helix A) of the two monomers are swapped in this dimer (Fig.
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2b), which is important for the catalysis by TDO because several
residues in this segment are part of the binding site for the Trp
residue in the active site (see below).
Binding Mode of the L-Trp Substrate to TDO. Our structure of the
binary complex defines the molecular mechanism for the recogni-
tion of the L-Trp substrate by TDO. Clear electron density was
observed for heme and L-Trp in the active site based on the
crystallographic analysis at 1.6-Å resolution (Fig. 3a). The L-Trp
substrate is located in a pocket over the distal face of the heme,
having interactions with residues in helices B and D, and the
D–E and J–K loops (Figs. 1b and 3b). The carboxylate group
of Trp is recognized by bidentate ion-pair interactions with the side
chain of Arg 117 (in helix D). The carboxylate group is also
hydrogen-bonded to the side chain hydroxyl of Tyr113 (helix D)
and themain chain amide of Thr 254 (J-K loop). The ammonium
ion of L-Trp is recognized by the 7-propionate side chain of the
heme group (Fig. 3b), and it is also hydrogen-bonded to the side
chain hydroxyl of Thr 254. The indole ring is located3.5 Å above
and perpendicular to the heme and is held in place by van derWaals
interactions with the side chains of Phe 51 (helix B) and several
other hydrophobic residues, including Tyr 24, Tyr 27, and Leu 28
from the N-terminal segment of another monomer of the tetramer
(Fig. 3b). In addition, the N1 nitrogen of the indole ring is
hydrogen-bonded to the side chain of His 55 (helix B) (Fig. 3b).
A water molecule is present in the active site of this binary
complex (Fig. 3a), hydrogen-bonded to the ammonium ion of
L-Trp and the main-chain amide of residue Gly 125 (Fig. 3b). The
water is 3.5 Å from the ferrous atom in the heme, too far for
ligating interactions. The iron atom is still 0.3 Å out of the plane
of the heme, on the side of the proximal His 240 ligand (SI
Fig. 5).
The crystal was exposed to a solution saturated with nitric
oxide (NO) before being flash-frozen, but we did not observe the
binding of this dioxygen analog in the structure. This is con-
firmed by our structure of the binary complex with 6-fluoro-Trp,
which was not exposed to NO but contained the same density for
the water molecule (SI Fig. 6). The structure of the 6-fluoro-Trp
binary complex is essentially identical to that of the L-Trp binary
complex (SI Fig. 6). NO probably dissociated from the heme
during the cryofreezing manipulations in the anaerobic box.
Induced-Fit Behavior of TDO. Our structural information suggests
that TDO is an induced-fit enzyme. Although the active site
Fig. 1. Primary structures of TDO and IDO. (a) The biochemical reaction
catalyzed by TDO and IDO. (b) Amino acid sequence alignment of X. campes-
tris TDO (XcTDO), human TDO (HsTDO), S. oneidensis SO4414 (SO4414), and
human IDO (HsIDO). The filled circles indicate residues involved in binding
L-Trp, and the diamonds indicate residues involved in binding heme. The
symbols for residues before helixA are given different colors, to indicate that
they are from another monomer of the tetramer.
Fig. 2. The structure of TDO. (a) Schematic representation of the structure
of the monomer of X. campestris TDO. The -helices are shown in yellow and
labeled. Heme is shown in gray, and L-Trp is shown in orange (labeled W). The
water molecule is shown as a red sphere (labeled wat). (b) Schematic repre-
sentation of the tetramer of X. campestris TDO. The four monomers are
colored in yellow, cyan, violet, and green. Helices in the tetramer interface are
labeled. The Trp molecules in the tetramer interface are also shown. Produced
with Molscript (35) and rendered with Raster3D (36).
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pocket is well defined in the binary complex (Fig. 3b), the J–K
loop, which helps to form the walls of this pocket, is disordered
in the free enzyme, and the D-E loop has a somewhat
different conformation (Fig. 3c; and see SI Fig. 7). Moreover, the
Arg 117 side chain assumes a different conformation in the free
enzyme (Fig. 3c). Upon recognition of the L-Trp substrate, a
complex and extensive network of interactions is established
(Fig. 3b), thus stabilizing the active site region. Although this
region is exposed to the solvent in the free enzyme, it is
completely shielded from the solvent in the binary complex, and
only the carboxylate group of the 6-propionate of heme is visible
on the surface.
Additional evidence for the induced-fit behavior is observed
in the active site of the second TDOmonomer in the asymmetric
unit. The binding mode of the L-Trp substrate is very different
in this monomer (Fig. 3d; and see SI Fig. 7). The Trp side chain
is not positioned as deeply into the pocket, and the hydrogen
bond between the ring nitrogen and the side chain of His 55 is
lost (distance of 3.8 Å). Both nitrogen atoms are instead
hydrogen-bonded to a water molecule, located 3.5 Å from the
heme iron but at a position distinct from that of the water in the
active site of the other monomer (Fig. 3d). This conformation
may also be stabilized by crystal packing interactions, as the
7-propionate of heme is ion-paired with an Arg residue from
another TDO tetramer in the crystal. The main chain atoms of
the Trp substrate appear to be disordered, because no clear
electron density was observed for them (Fig. 3e). Consistent with
this finding, the J–K loop is disordered in this molecule,
similar to that in the free enzyme (Fig. 3d). This complex may
represent an initial stage in the formation of the Michaelis
complex of TDO. Proper positioning of the L-Trp substrate for
catalysis would lead to the recognition of its main chain atoms
and the ordering of the J–K loop.
Implications for Substrate Binding by IDO. Our structure of the
binary complex of TDO also has significant implications for
substrate recognition by the IDOs. The rms distance for 201
structurally equivalent C atoms between TDO and the large
domain of human IDO (PDB entry 2D0T) (14) is 3.1 Å (SI Fig.
8), calculated with the program Dali (17). Despite sharing only
10% overall sequence identity, key active-site residues are
similar in TDO and IDO (Fig. 1b; and see SI Table 4), and L-Trp
may have the same binding mode to the active site of IDO (SI
Fig. 9). Ionic interactions that are important for recognizing the
L-Trp ammonium ion and carboxylate group are conserved in
IDO (Arg 231 and 7-propionate), explaining why L-Trp is a much
better substrate than D-Trp for IDO. At the same time, hydro-
gen-bonding interactions to these atoms may be absent in IDO,
because Tyr 113 of TDO is replaced by Phe 226 in IDO (SI Fig.
9), and the Thr 254 residue may not have an equivalent in IDO
because the J–K loop, disordered in the IDO structure (SI Fig.
9) (14), has highly divergent sequences in IDO compared with
TDO (Fig. 1b). Therefore, IDO may have weaker interactions
with tryptophan, which may be the reason why it cannot com-
pletely distinguish among the indoleamine substrates.
The structure comparison explains why 1-methyltryptophan is
a micromolar inhibitor of IDO (18) but is essentially inactive
against TDO (10). The N1 atom is directly hydrogen-bonded to
the His 55 side chain in TDO (Fig. 3b), and its methylation will
cause steric clash with this residue. In comparison, His 55 is
replaced by Ser 167 in IDO (SI Table 4), which creates a small
pocket that can accommodate the 1-methyl group (SI Fig. 9).
Structural similarity is also observed with the SO4414 protein
from S. oneidensis (SI Fig. 8) (16), with an rms distance of 4.4 Å
for 206 equivalent C atoms, suggesting that SO4414 may also
be a dioxygenase. Moreover, the structure contains an extra
domain that is formed by residues at the N terminus, similar to
the small domain in human IDO (SI Fig. 8). In contrast to human
IDO, SO4414 is a tetramer but with a different organization
compared with that of TDO (SI Fig. 10). Our biochemical efforts
so far have not been able to demonstrate IDO (or TDO) activity
for this protein, suggesting that SO4414 may prefer a different
substrate for oxygenation.
A Model for the Michaelis Complex. To help provide further insight
into the catalysis by these enzymes, we built a model for the
Michaelis complex, by placing one oxygen atom (O1) of the
dioxygen substrate directly over the heme iron, at a distance
of 2.1 Å (Fig. 4a). The distal oxygen atom (O2) was placed such
that theO1–O2 bond is parallel to the C2–C3 bond of indole ring,
giving a Fe–O1–O2 angle of 135°. This conformation places the
O2 atom within 0.5 Å of the water molecule observed in our
structure (Fig. 4a), suggesting that this water should be ejected
from the active site upon dioxygen binding. The active site is
therefore completely devoid of solvent molecules in this Michae-
lis complex.
The modeled dioxygen-binding mode reveals the activation
mechanism of this substrate for the reaction. It has been
established that TDO has an ordered catalytic cycle in which the
protein first binds L-Trp to the ferrous form, and then binding
of dioxygen is facilitated, and nucleophilic attack from the
substrate C3 is initiated (3, 13, 19). In the model, the distal
oxygen atom interacts with the L-Trp ammonium moiety and the
backbone amide nitrogen of Gly 125 (Fig. 4a). The Lewis acidity
Table 1. Summary of crystallographic information
Protein
TDO
(holoenzyme)
TDO
(holoenzyme)
TDO
(holoenzyme)
TDO
(apoenzyme)
SO4414
(holoenzyme)
SO4414
(apoenzyme)
Ligand L-Trp 6-fluoro-Trp None None None None
Maximum resolution, Å 1.6 1.8 2.7 2.7 2.4 2.3
Rmerge, %* 6.9 (52.7) 8.6 (60.9) 13.0 (32.3) 16.6 (74.0) 10.4 (63.0) 6.6 (30.6)
Beam line ESRF BM14 ESRF BM14 NSLS X4A APS 21BM NSLS X4A NSLS X4A
Completeness, % 87 (65) 87 (61) 72 (54) 82 (68) 83 (60) 87 (71)
R factor, %† 17.1 (18.9) 16.6 (17.9) 25.7 (25.7) 25.0 (32.1) 21.7 (23.5) 23.4 (26.7)
Free R factor, % 18.9 (22.0) 18.4 (21.1) 26.3 (26.2) 29.4 (35.1) 22.5 (24.1) 27.5 (31.5)
rms deviation in bond
lengths, Å
0.005 0.005 0.008 0.011 0.007 0.006
rms deviation in bond
angles, °
1.0 1.0 1.2 1.6 1.1 1.0
Most-favored region, % 92 91 89 86 92 91
*Rmerge  hiIhiIhhiIhi. The numbers in parentheses are for the highest-resolution shell.
†R  hFh
o  Fh
chFh
o.
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of the hydrogen-bonding donors, coupled with the electron-
withdrawing nature of the heme, would increase the electrophi-
licity of the bound dioxygen and render it more susceptible to
nucleophilic attack by the substrate C3 atom. The increased
hydrophobicity of the active site upon the exclusion of water
would also aid the stabilization of an oxyferrous species. Studies
with heme oxygenase suggest that the hydrogen-bonding inter-
actions to the dioxygen substrate may also help to prevent its
heterolysis (20), and the exclusion of water probably removes a
hydrogen-bond competitor to the dioxygen. After the initial
attack by the C3 atom, the reaction may proceed via a Criegee
rearrangement or a dioxetane intermediate (SI Fig. 11). In the
model, the O1–O2 atoms are in a trans configuration relative to
the C2–C3 atoms of L-Trp (Fig. 4a), which may favor the Criegee
rearrangement pathway (SI Fig. 11) (19). The Criegee pathway
is also favored based on chemical, thermodynamic, and quantum
mechanical considerations (3).
Our model for the Michaelis complex shows that the O1 atom
is 2.6 Å from the N1 atom of L-Trp and therefore can act as the
general base to extract the proton from the N1 atom (SI Fig. 11)
(19). The N1 atom is hydrogen-bonded to His 55 in TDO.
However, our biochemical studies show that the kcat of TDO is
relatively insensitive to pH over the range examined (pH 6 to pH
8) (Fig. 4b), and the H55A mutant had only a 10-fold decrease
in the kcat (Table 2), suggesting that this residue is not essential
for catalysis, consistent with its replacement with a Ser residue
in IDO. On the other hand, the Km shows a marked increase at
lower pH (Fig. 4b), probably because of the protonation of this
residue.
An Allosteric Binding Site in the Tetramer Interface. We also ob-
served the binding of four L-Trp residues to an allosteric site in
the interface of the tetramer (Fig. 2b), with well defined electron
density (SI Fig. 12). The L-Trp residue appears to be recognized
specifically by the enzyme in this pocket (SI Fig. 12). There have
been reports of allosteric activation by the substrate L-Trp (21,
22), and our observations offer a possibility for this effector site.
Unfortunately, our kinetic studies so far have not shown any
allosteric effects with X. campestris TDO. This site is not
occupied in the 6-fluoro-Trp complex, possibly because of the
lower concentration of this compound in the crystallization
solution.
Biochemical Studies Confirm the Structural Observations. X. campes-
tris TDO has robust catalytic activity toward L-Trp and 6-fluoro-
Trp but is inactive toward D-Trp, tryptamine or indolepropionic
acid (Table 2), confirming its designation as a TDO. In fact,
D-Trp is a weak, competitive inhibitor of the enzyme at high
concentrations (Table 2). Our binding data show that D-Trp has
much lower affinity for the enzyme than L-Trp (Table 2),
consistent with our structural information and explaining why
D-Trp cannot be oxygenated by TDO.
The biochemical studies also provide direct evidence for the
induced-fit behavior of TDO. There is a large increase in the
affinity of the enzyme for L-Trp when the heme iron is reduced
(Kd [ferric Fe(III) heme]  3.8 mM, whereas Kd [ferrous Fe(II)
heme]  4.1 M) (Table 2). The electrochemistry data show a
large, positive shift in reduction potential (136 mV) in the
presence of 15 mM L-Trp (Fig. 4c). In fact, the shift in reduction
potential almost perfectly correlates with the increase in affinity
for L-Trp on reduction, both giving an estimated G of 15
kJ/mol. These data show that there is a significant stabilization
of the ferrous form when substrate is bound. This stabilization
could also play a physiological role to keep the protein reduced,
and therefore active, when L-Trp is present.
Our structural studies have defined the binding mode of the
substrate L-Trp to TDO, revealing the structural basis for the
stereospecificity of this important enzyme. The induced-fit
behavior of TDO, confirmed by our biophysical studies, appears
crucial for the exclusion of water from the active site and for
stabilizing the enzyme in the presence of the substrates. Finally,
structural comparisons among these enzymes reveal the striking
evolutionary conservation of the heme-dependent dioxygenases.
Materials and Methods
The experimental protocols are summarized here. More de-
tailed information can be found in SI Materials and Methods.
Protein Expression and Purification. Full-length X. campestris TDO
(NESG IDXcR13) and S. oneidensis SO4414 (NESG ID SoR52)
were cloned into a pET-21d (Novagen, San Diego, CA) deriv-
ative, with a C-terminal hexahistidine tag, and overexpressed at
17°C in Escherichia coli BL21(DE3) pMGK cells. Hemin (7 M
Fig. 3. Molecular basis for substrate recognition by TDO. (a) Final 2FoFc
electron density at 1.6-Å resolution for heme, L-Trp, and a water in the active
site. Contoured at 1. (b) Stereo drawing showing the active site of X.
campestris TDO in the binary complex with L-Trp. The segment in cyan is from
another monomer of the tetramer. Hydrogen-bonding interactions are indi-
cated with dashed lines in magenta. (c) Overlay of the structures of the free
enzyme (in orchid) and the binary complex (yellow and cyan) in the active-site
region. Regions of conformational differences are indicated with the red
arrows. (d) Overlay of the active-site region of the second monomer (in green)
and that of the first monomer (in yellow). Only the side-chain atoms of Trp are
shown in the second monomer (in magenta). (e) Final 2FoFc electron density
at 1.6-Å resolution for heme, L-Trp, and a water in the active site of the second
TDO molecule in the crystal. Contoured at 1. Two conformations for the main
chain atoms are shown, but neither fit the density well. For the stereo version
of c and d, please see SI Fig. 7. Produced with Molscript (35) and rendered with
Raster3D (36).
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final concentration) was included in the media for preparation
of the holoenzyme samples (23). The protein was purified by
using nickel-affinity and gel-filtration chromatography.
Point mutations were created with the QuikChange II site-
directed mutagenesis kit (Stratagene, La Jolla, CA). The mu-
tations and their associated ORFs were verified by DNA se-
quence analysis.
Protein Crystallization. To obtain the structure of TDO in the
ferrous state, the protein was reduced by the addition of sodium
dithionite, and all steps were performed in an anaerobic glove box
(Belle Technology, Dorset, U.K.), with the O2 concentration main-
tained 	2 ppm. Excess sodium dithionite was removed by gel
filtration (SephadexG25 column) before crystallization. Crystals of
TDO were grown by the sitting-drop vapor diffusion method with
a well solution comprising 100 mMMes (pH 6.3), 10–12% (wt/vol)
PEG 4000, 60 mM MnCl2, 10 mM sodium dithionite, and 2 mM
L-Trp. Before mounting in nylon loops and flash-freezing in liquid
nitrogen, crystals were immersed in a cryoprotectant solution
composed of mother liquor (with L-Trp concentration increased to
50 mM) supplemented with 23% (vol/vol) glycerol and bubbled
with nitric oxide for 15 min before use.
Data Collection and Processing. X-ray diffraction data were col-
lected at the X4A beam line of National Synchrotron Light
Source (Brookhaven National Laboratory, Upton, NY), the
21BM beam line at Advanced Photon Source (Argonne National
Laboratory, Argonne, IL), and the BM14 beam line at the
Fig. 4. Molecular insights into the catalysis by TDO. (a) Model of the Michaelis complex. The water molecule is shown as a small sphere in green. Produced with
Molscript (35) and rendered with Raster3D (36). (b) The pH dependence of the kcat and Km values of X. campestris TDO. (c) The presence of L-Trp causes a large,
positive shift in the reduction potential of TDO. SHE, standard hydrogen electrode.
Table 2. Summary of kinetic data on X. campestris TDO
Enzyme Substrate kcat(s1) Km, M
Kd
Ferric
heme, mM
Ferrous
heme, M
Wild type
L-Trp 19.5 
 1.2 114 
 1 3.84 
 0.14 4.12 
 0.24
D-Trp 0 16.5 mM 
 3.3* 50† NC
6-F-DL-Trp 37.3 
 0.6 186 
 12 2.45 
 0.42 	1†
5-F-DL-Trp 2.40 
 0.10 100 
 6 1.51 
 0.08 	1‡
Indolepropionic acid 0 0 10† 126 
 11
O2§ 35.4 
 0.9 119 
 2 0 NA
H55A mutant L-Trp 2.86 
 0.10 133 
 7 ND 3.7 
 1.3
NA, Kd for O2 cannot be measured in the absence of substrate because of oxidation or in the presence of
substrate because of turnover; NC, No spectral change detected; ND, not done.
*Inhibitory constant, Ki.
†Although a spectral change was evident, substrate solubility prevented accurate measurement ofKd. Values were
estimated based on the maximum substrate concentration attainable.
‡Binding was too tight to be measured. Values quoted represent the minimum Kd that can be measured under
standard assay conditions.
§The peak positions of the oxyferrous complex (O2-TDO) are at 420 nm, 548 nm, and 578 nm.
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European Synchrotron Radiation Facility (Grenoble, France).
The diffraction images were processed and scaled with the HKL
package (24). The data-processing statistics are summarized in
Table 1, and more complete information can be found in
SI Table 3.
Structure Determination and Refinement. The structures of the apo
enzymes of TDO and SO4414 were determined by the selenome-
thionyl single-wavelength anomalous diffraction method (15).
The selenium sites were located with SnB (25), and the reflection
phases were calculated with Solve/Resolve (26). The structures
of the holoenzymes and the ternary complex were determined by
the molecular-replacement method, with the programs COMO
(27) and AMoRe (28). The atomic models were built with the
program XtalView (29) and TURBO-FRODO (30), and the
structure refinement was carried out with CNS (31).
Electronic Spectroscopy, Steady-State Assays, and Dissociation Con-
stant Measurements.Electronic absorption spectra were recorded
by using a Cary 50-Probe UV-Visible spectrophotometer at
25°C. Assays for the steady-state turnover (at pH 7.5) of L-Trp
and derivatives were performed as described (32, 33), except that
substrate concentrations of 0–15 mM were used. The kinetic
data were fitted to the Michaelis–Menten equation. The pH
dependence of the steady-state kinetics was determined in the
same manner, by using phosphate (pH 6.0–8.0) and Tris (pH
8.0–9.0) buffers. The electronic absorption spectra of the steady
state were recorded by using a stopped-flow spectrophotometer
(SX.17MV; Applied-Photophysics, Surrey, U.K.) in conjunction
with a diode array detector, housed in an anaerobic glove box
([O2], 	5 ppm; Belle Technology).
OTTLE Electrochemistry. Anaerobic potentiometric titrations were
carried out as described (34) at 25°C by using a modified quartz
EPR OTTLE cell. Titrations were performed in both the
absence and presence of L-Trp (15 mM), and the heme reduction
potentials were determined by fitting the data to the Nernst
equation for a single-electron process by using Origin software
(MicroCal, Northampton, MA). Reduction potentials are
quoted versus the standard hydrogen electrode.
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